Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardioprotective and neuroprotective effects of dexmedetomidine in cardiac surgery via modulation of miR-499 and miR-93
TCTR20180912005Active, not recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in Myocardial injury and neurologic injury (2 arms), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoints: Change in miR-499 expression and Change in miR-93 expression. Started May 2018; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Myocardial injuryneurologic injury
Beyond the preview
Go deeper on TCTR20180912005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180912005.